Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

SAN CARLOS, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended September 30, 2010.

Cash, cash equivalents, and short-term investments at September 30, 2010 were $303.3 million as compared to $396.2 million at December 31, 2009.

Revenue for the third quarter of 2010 increased to $37.9 million as compared to $10.2 million in the third quarter of 2009.  The increase in revenue year over year is largely the result of the amortization of the $125 million milestone payment received from AstraZeneca in September 2009 under the partnership agreement for NKTR-118.  

Total operating costs and expenses in the third quarter of 2010 were $44.2 million compared to $39.1 million in the third quarter 2009. The increase in total operating costs and expenses was primarily due to an increase in research and development expenses.

Research and development expenses were $27.7 million and increased by 20% in the third quarter of 2010 as compared to $23.0 million for the same quarter in 2009.  General and administrative expense increased slightly to $10.2 million in the third quarter 2010 from $9.9 million in the third quarter of 2009.

“Nektar’s continued productivity in research and development has resulted in a deep pipeline of programs that range from those in preclinical research to those preparing for Phase 3,” said Howard W. Robin, President and Chief Executive Officer of Nektar.  “With our Phase 2 data this year from our exciting oncology candidate, NKTR-102, and the preclinical data from our new opioid candidate, NKTR-181, we continue to demonstrate the value of Nektar’s proprietary polymer conjugate technology.”

Net loss for the third quarter ended September 30, 2010 decreased to $8.7 million or $0.09 per share
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015  The U.S. Food and ... Sense4Baby™ wireless maternal/fetal monitoring system to ... pregnant patients to self-administer non-stress tests (NST). ... FDA for use accompanied by medical professionals. Sense4Baby ... Commission in 2013 for self-administration, including the home. ...
(Date:4/1/2015)... SAN DIEGO , April 1, 2015 MEI ... on the clinical development of novel therapies for cancer, announced ... Chief Executive Officer, will present at the 14 th ... 1:40 p.m. Eastern time from the Westin Grand Central Hotel ... of the presentation can be accessed at www.meipharma.com . ...
(Date:4/1/2015)... and WILMINGTON, N.C. , April 1, ... third among all CROs in the 2015 CenterWatch survey ... Chiltern,s high ranking, Susan Romberg , Vice President ... to say ,Thank You, to the all the clinical ... the benefits of specialization through having a deep understanding ...
Breaking Medicine Technology:AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4MEI Pharma to Present at Needham Healthcare Conference 2Chiltern Ranks Among Top CROs In Global Survey Of Clinical Research Sites 2
... UNION CITY, Calif., July 19, 2011 Abaxis, Inc. (NasdaqGS: ... has scheduled a conference call to discuss its financial results ... 30, 2011. The call will be at 4:15 p.m. ET ... results for the first quarter of fiscal year 2012 after ...
... MSC Care Management, a national leader in delivery of ... compensation industry, helps claims professionals save on open and ... solution. By directing new and recurring transactions to MSC,s ... contracted rates with in-network providers, which are an average ...
Cached Medicine Technology:Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011 2MSC CareSync+ Bill Management Maximizes Savings on Each Transaction 2
(Date:4/1/2015)... 01, 2015 IQ Formulations , one ... nutritional supplement companies in the U.S., today is commending GNC ... quality control standards for its herbal supplements.* GNC vowed that ... to ensure the accuracy of labeling on its products. ... IQ Formulations CEO Jay Cohen said: , ...
(Date:4/1/2015)... PA (PRWEB) April 01, 2015 Health ... company and a subsidiary of West Corporation, today launched ... at http://blog.healthadvocate.com and through the Health Advocate ... healthcare consumers get, and stay, healthy. , “We’re pleased ... available to the public,” said Martin Rosen, Executive Vice ...
(Date:4/1/2015)... WI (PRWEB) April 01, 2015 When ... dryness occur, waiting days or weeks for an appointment ... Historically same and next day appointments haven’t been possible ... area, Forefront Dermatology’s offices have noticed demand for this ... , “We realize how important relief or answers to ...
(Date:4/1/2015)... 01, 2015 Senior Helpers of Central ... Care Provider of Choice Award by Home Care Pulse. The ... is given to home care providers who receive the highest ... for quality in home care. This recognition reassures you that ... will provide you with quality, trustworthy in home care. , ...
(Date:4/1/2015)... 01, 2015 The 2015 Deep ... is a professional and in-depth study on the ... Market with a focus on the Chinese ... market research are Pfizer, Lek Pharmaceuticals D.D., Dr ... India Private Limited, Cadila Healthcare Limited, Sandoz Inc, ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3
... , , INDIANAPOLIS, ... it will begin marketing its 2010 Medicare Advantage and 2010 Medicare Part ... beneficiaries in its Medicare Advantage and Medicare Part D health benefit plans ... , The Centers for Medicare and Medicaid Services (CMS) has ...
... , , DENVER, Sept. 9 ... kidney care services for those diagnosed with chronic kidney disease (CKD), ... optimal patient care standards and social circumstances. , , ... 16, is not your everyday student at Hollywood High School in ...
... confirmed previous findings that the sexual transmitted infection known ... increased risk of prostate cancer in a study published ... National Cancer Institute . Jennifer Rider Stark, ScD, ... of Public Health in Boston, and colleagues conducted a ...
... H1N1 influenza vaccine in pregnant women is launching this ... (NIAID), part of the National Institutes of Health, announced ... severe illness if they become infected with influenza virus ... to receive the seasonal influenza vaccine every year," says ...
... , SAN FRANCISCO, Sept. 9 Blue Shield of ... the H1N1 virus (swine flu) vaccine for all its members, regardless ... prior authorizations, copays and deductibles for office visits when members go ... , The U.S. Government will be providing H1N1 ...
... awaken dormant, common virus that crosses over into brain , ... part of the reason why Tysabri, a drug used to ... rare but potentially deadly brain disease in some patients. , ... from its slumber, allowing it to cross into the brain. ...
Cached Medicine News:Health News:Statement on WellPoint's Re-Entry into Medicare Market 2Health News:DaVita's Patient-Centric Modalities Offer Students with Kidney Disease More Choices 2Health News:JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer 2Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3
... Medic 6 Defibrillator is a simple ... response that is compact with a ... portable at only 13.5 lbs. It ... 360 joules,It has full summary pre- ...
Incontinence Pessaries...
HODGE with support designed for patient with limited pubic notch and mild cystocele. The folding HODGE Pessary with Support is indicated for the woman with stress urinary incontinence with a mild cyc...
... Incontinence Ring Pessary is ... with urinary stress incontinence. ... continence by stabilizing the ... active enhancement of urethral ...
Medicine Products: